NYU Grossman’s Preeya Mehta, MD, and Jonathan S. Williams, MD, sit down with Mount Sinai’s Louis R. Pasquale, MD, to discuss long-term safety and efficacy data from a PreserFlo microshunt trial and ...
AI is reshaping clinical practice in retinal imaging and workflow optimization, according to Priv.-Doz. Dr. med. Jan H.
Andrew Tatham, MD, MBA, FRCOphth, FEBO, outlines the role of micro-invasive glaucoma surgery alongside established glaucoma ...
The IPL's microstructure may serve as a biomarker for early diagnosis of diseases affecting synaptic health, including ...
At the 2nd International Glaucoma Symposium in Mainz, Germany, on 31 January 2026, optical coherence tomography (OCT) and its role in glaucoma and neuro-ophthalmic disease took centre stage in a ...
Implement targeted therapies in treatment plans to eradicate Demodex and improve outcomes in patients with Demodex ...
The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...
To learn more about this topic, including the diagnosis and interdisciplinary management of MacTel, go to ...
The FDA approved re-administration of iDose TR for patients with healthy corneas, enhancing treatment flexibility for ...
As the 2nd International Glaucoma Symposium approaches in Mainz, Germany, Stephan Schulz highlights how the program bridges everyday clinical needs with the latest advances in AI, imaging, and surgery ...
The study highlights the importance of shear-thinning behavior in artificial tears, crucial for mimicking natural tear ...
Belite Bio completes enrollment in phase 2/3 DRAGON II clinical trial evaluating tinlarebant for the treatment of Stargardt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results